Cited by 483Pancreatic function and diabetesDiabetes and associated disordersDiabetes Treatment and Management

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Open access

Ward, W K, Bolgiano, D C, McKnight, B, Halter, J B, Porte, D·1984·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

In order to assess whether patients with noninsulin-dependent diabetes mellitus (NIDDM) possess normal insulin secretory capacity, maximal B cell responsiveness to the potentiating effects of glucose was estimated in eight untreated patients with NIDDM and in eight nondiabetic controls. The acute insulin response to 5 g intravenous arginine was measured at five matched plasma glucose levels that ranged from approximately 100-615 mg/dl. The upper asymptote approached by acute insulin responses (AIRmax) and the plasma glucose concentration at half-maximal responsiveness (PG50) were estimated using nonlinear regression to fit a modification of the Michaelis-Menten equation. In addition, glucagon responses to arginine were measured at these same glucose levels to compare maximal A cell suppression by hyperglycemia in diabetics and controls. Insulin responses to arginine were lower in diabetics than in controls at all matched glucose levels (P less than 0.001 at all levels). In addition, estimated AIRmax was much lower in diabetics than in controls (83 +/- 21 vs. 450 +/- 93 microU/ml, P less than 0.01). In contrast, PG50 was similar in diabetics and controls (234 +/- 28 vs. 197 +/- 20 mg/dl, P equals NS) and insulin responses in both groups approached or attained maxima at a glucose level of approximately 460 mg/dl. Acute glucagon responses to arginine in patients with NIDDM were significantly higher than responses in controls at all glucose levels. In addition, although glucagon responses in control subjects reached a minimum at a glucose level of approximately 460 mg/dl, responses in diabetics declined continuously throughout the glucose range and did not reach a minimum. Thus, A cell sensitivity to changes in glucose level may be diminished in patients with NIDDM. In summary, patients with NIDDM possess markedly decreased maximal insulin responsiveness to the potentiating effects of glucose. Such a defect indicates the presence of a reduced B cell secretory capacity and suggests a marked generalized impairment of B cell function in patients with NIDDM.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci111542

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Exploratory Data Analysis
David, F. N., & Tukey, J. W. (1977) · Biometrics · doi:10.2307/2529486 · Cited by 12,707
Applied Regression Analysis
Hahn, G. J., Draper, N. R., & Smith, H. C. (1982) · Technometrics · doi:10.2307/1267833 · Cited by 5,820
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Exploratory Data Analysis
Tukey, J. W. (1977) · International Linear Collider · Cited by 2,155
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Effects of arterial versus venous sampling on analysis of glucose kinetics in man
McGuire, E. A., Helderman, J. H., Tobin, J. D., Andres, R., & Berman, M. D. (1976) · Journal of Applied Physiology · doi:10.1152/jappl.1976.41.4.565 · Cited by 704
A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling
Grodsky, G. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci107011 · Cited by 391
Insulin secretion in diabetes mellitus
Pfeifer, M. A., Halter, J. B., & Porte, D. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90579-9 · Cited by 367
Self-citation
The pancreatic islets in diabetes
Gepts, W., & LeCompte, P. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90417-4 · Cited by 348
Glucagon and the a Cell
Unger, R. H., & Orci, L. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106183042504 · Cited by 303

Show all 37 references

Sorted by citations

Items 201–300 of 482

Islet Function and Insulin Sensitivity in the Non‐diabetic Offspring of Conjugal Type 2 Diabetic Patients
Johnston, C., Ward, W. K., Beard, J. C., McKnight, B., & Porte, D. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01345.x · Cited by 46
Self-citation
β- and α-Cell Dysfunctions in Africans With Ketosis-Prone Atypical Diabetes During Near-Normoglycemic Remission
Choukem, S. P., Sobngwi, E., Boudou, P., Fetita, L.-S., Porcher, R., Ibrahim, F., Blondeau, B., Vexiau, P., Mauvais‐Jarvis, F., Calvo, F. M., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0798 · Cited by 43
Changes in beta cell function occur in prediabetes and early disease in the Lepr db mouse model of diabetes
Do, O. H., Gunton, J. E., Gaisano, H. Y., & Thorn, P. (2016) · Diabetologia · doi:10.1007/s00125-016-3942-3 · Cited by 46
Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance1
Larsson, H., & Åhrén, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5717 · Cited by 43
Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization
Yoshiuchi, I., Yamagata, K., Yang, Q., Iwahashi, H., Okita, K., Yamamoto, K., Oue, T., Imagawa, A., Hamaguchi, T., Yamasaki, T., et al. (1999) · Diabetologia · doi:10.1007/s001250051204 · Cited by 44
Insulin deficiency and insulin resistance in Type 2 (non‐insulin‐dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis
Нешер, Р., Casa, L. D., LITVIN, Y., Sinai, J., Rió, G. D., Pevsner, B., Wax, Y., & Cerasi, E. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01247.x · Cited by 43
Does Disruption of Circadian Rhythms Contribute to Beta-Cell Failure in Type 2 Diabetes?
Rakshit, K., Thomas, A. P., & Matveyenko, A. V. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0474-4 · Cited by 42
Prevention of Complications in Non-Insulin-Dependent Diabetes Mellitus (NIDDM)
Wolffenbuttel, B. H. R., & van Haeften, T. W. (1995) · Drugs · doi:10.2165/00003495-199550020-00006 · Cited by 42
Measurements of insulin responses as predictive markers of pancreatic β-cell mass in normal and β-cell-reduced lean and obese Göttingen minipigs in vivo
Larsen, M. O., Rolin, B., Sturis, J., Wilken, M., Carr, R. D., Porksen, N., & Gotfredsen, C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00251.2005 · Cited by 45
A Novel Insulin Delivery Algorithm in Rats With Type 1 Diabetes: The Fading Memory Proportional‐Derivative Method
Gopakumaran, B., Duman, H. M., Overholser, D. P., Federiuk, I. F., Quinn, M. J., Wood, M. D., & Ward, W. K. (2005) · Artificial Organs · doi:10.1111/j.1525-1594.2005.29096.x · Cited by 41
Self-citation
Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
Gudipaty, L., Rosenfeld, N. K., Fuller, C. S., Gallop, R., Schutta, M. H., & Rickels, M. R. (2014) · Diabetes Care · doi:10.2337/dc14-0398 · Cited by 41
Defects in β-Cell Function and Insulin Sensitivity in Normoglycemic Streptozocin-Treated Baboons: A Model of Preclinical Insulin-Dependent Diabetes*
Mcculloch, D., Raghu, P., Johnston, C., Klaff, L., Kahn, S., Beard, J. C., Ward, W., Benson, E. A., Koerker, D., Bergman, R., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-785 · Cited by 43
Self-citation
Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects
Meier, J. J., Nauck, M. A., Siepmann, N., Greulich, M., Holst, J. J., Deacon, C. F., Schmidt, W. E., & Gallwitz, B. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00327-5 · Cited by 41
Chronic Reduction of Fasting Glycemia With Insulin Glargine Improves First- and Second-Phase Insulin Secretion in Patients With Type 2 Diabetes
Pennartz, C., Schenker, N., Menge, B. A., Schmidt, W. E., Nauck, M. A., & Meier, J. J. (2011) · Diabetes Care · doi:10.2337/dc11-0471 · Cited by 38
Glucagon secretion in relation to insulin sensitivity in healthy subjects
Åhrén, B. (2005) · Diabetologia · doi:10.1007/s00125-005-0056-8 · Cited by 40
Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance
Larsson, H. E., Berglund, G., & Åhrén, B. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.6.7775622 · Cited by 41
Pathogenesis of non-insulin-dependent (type II) diabetes mellitus (NIDDM) – genetic predisposition and metabolic abnormalities
Jun, H., Bae, H. Y., Lee, B. R., Koh, K. S., Kim, Y., Lee, K. W., Kim, H., & Yoon, J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00071-4 · Cited by 40
Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects
Merovci, A., Tripathy, D., Chen, X., Valdez, I., Abdul‐Ghani, M. A., Solis‐Herrera, C., Gastaldelli, A., & DeFronzo, R. A. (2020) · Diabetes · doi:10.2337/db20-0039 · Cited by 45
Impact of nicotinic acid treatment on insulin secretion and insulin sensitivity in low and high insulin responders
Alvarsson, M., & Grill, V. (1996) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519609088812 · Cited by 39
Dose-Response Characteristics for Arginine-Stimulated Insulin Secretion in Man and Influence of Hyperglycemia *
van Haeften, T. W., Voetberg, G. A., Gerich, J. E., & van der Veen, E. A. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-5-1059 · Cited by 39
Diminished arginine-stimulated insulin secretion in trained men
Dela, F., Mikines, K. J., Tronier, B., & Galbo, H. (1990) · Journal of Applied Physiology · doi:10.1152/jappl.1990.69.1.261 · Cited by 38
Glucose regulation in non-insulin-dependent diabetes mellitus: Interaction between pancreatic islets and the liver
Halter, J. B., Ward, W. K., Porte, D., Best, J. D., & Pfeifer, M. A. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90579-0 · Cited by 38
Self-citation
Ketosis-Prone Type 2 Diabetes: Effect of Hyperglycemia on β-Cell Function and Skeletal Muscle Insulin Signaling
Umpierrez, G. E., Smiley, D. D., Gosmanov, A. R., & Thomason, D. B. (2007) · Endocrine Practice · doi:10.4158/ep.13.3.283 · Cited by 40
Pathophysiology of Diabetes Mellitus Type 2: Roles of Obesity, Insulin Resistance and &Bgr;-Cell Dysfunction
Thévenod, F. (2008) · Frontiers in diabetes · doi:10.1159/000152019 · Cited by 38
Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas.
Stagner, J. I., Samols, E., Polonsky, K. S., & Pugh, W. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112702 · Cited by 37
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Vilsbøll, T., Toft-Nielsen, M.-B., Krarup, T., Madsbad, S., Dinesen, B., & Holst, J. J. (2000) · Diabetes Care · doi:10.2337/diacare.23.6.807 · Cited by 37
Modeling Of Insulin Action In Vivo
Bergman, R. N., Steil, G. M., Bradley, D. C., & Watanabe, R. M. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004241 · Cited by 36
Effect of Insulin‐Induced Hypoglycaemia on the Central Nervous System : Evidence from Experimental Studies
Jensen, V. F. H., Bøgh, I. B., & Lykkesfeldt, J. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12133 · Cited by 41
Insulin secretion and glucose metabolism in alpha 1,3‐galactosyltransferase knock‐out pigs compared to wild‐type pigs
Casu, A., Echeverri, G. J., Bottino, R., van der Windt, D. J., He, J., Ekser, B., Ball, S. F., Ayares, D., & Cooper, D. K. C. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00572.x · Cited by 36
Effects of Intravenous Glucose Load on Insulin Secretion in Patients With Ketosis-Prone Diabetes During Near-Normoglycemia Remission
Gosmanov, A. R., Smiley, D. D., Robalino, G., Siqueira, J., Peng, L., Kitabchi, A. E., & Umpierrez, G. E. (2010) · Diabetes Care · doi:10.2337/dc09-1687 · Cited by 36
On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
Vilsbøll, T. (2004) · PubMed · Cited by 36
Secretion and Hepatic Extraction of Insulin After Weight Loss in Obese Noninsulin-Dependent Diabetes Mellitus*
Henry, R. R., Brechtel, G., & Griver, K. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-979 · Cited by 36
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production
Rohli, K. E., Boyer, C. K., Blom, S. E., & Stephens, S. B. (2022) · Biomolecules · doi:10.3390/biom12020335 · Cited by 36
The β-cell glucose toxicity hypothesis: Attractive but difficult to prove
Weir, G. C., Butler, P. C., & Bonner‐Weir, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154870 · Cited by 35
The contribution of incretin hormones to the pathogenesis of type 2 diabetes
Meier, J. J. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.03.007 · Cited by 34
Leptin—A regulator of islet function?: Its plasma levels correlate with glucagon and insulin secretion in healthy women
Åhrén, B., & Larsson, H. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90152-9 · Cited by 34
Influence of gliclazide on glucose-stimulated insulin release in man
van Haeften, T. W., Veneman, T. F., Gerich, J. E., & van der Veen, E. A. (1991) · Metabolism · doi:10.1016/0026-0495(91)90096-f · Cited by 32
Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary Artery Disease—State of the Art
Jonik, S., Marchel, M., Grabowski, M., Opolski, G., & Mazurek, T. (2022) · Biology · doi:10.3390/biology11020288 · Cited by 33
Biological Activity and Antidiabetic Potential of C-Terminal Octapeptide Fragments of the Gut-Derived Hormone Xenin
Martin, C. M., Parthsarathy, V., Hasib, A., Ng, M. T., McClean, S., Flatt, P. R., Gault, V. A., & Irwin, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152818 · Cited by 32
Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger
Novelli, M., Bonamassa, B., Masini, M., Funel, N., Canistro, D., Tata, V. D., Martano, M., Soleti, A., Campani, D., Paolini, M., et al. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0524-7 · Cited by 31
A common variant upstream of the PAX6 gene influences islet function in man
Ahlqvist, E., Turrini, F., Lang, S., Taneera, J., Zhou, Y., Almgren, P., Hansson, O., Isomaa, B., Tuomilehto, J., Eriksson, K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2300-8 · Cited by 33
Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets
Ishiyama, N., Ravier, M. A., & Henquin, J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2005 · Cited by 31
Chronic fractalkine administration improves glucose tolerance and pancreatic endocrine function
Riopel, M., Seo, J. B., Bandyopadhyay, G. K., Li, P., Wollam, J., Chung, H., Jung, S., Murphy, A. N., Wilson, M. E., de Jong, R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94330 · Cited by 31
Acute insulin response (AIR): review of protocols and clinical interest in islet transplantation
Marcelli-Tourvieille, S., Hübert, T., Pattou, F. N., & Vantyghem, M. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70283-5 · Cited by 32
Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release
van Haeften, T. W., Boonstra, E., Veneman, T. F., Gerich, J. E., & van der Veen, E. A. (1990) · Metabolism · doi:10.1016/0026-0495(90)90186-g · Cited by 30
Sulfonylurea Signal Transduction
BOYD, A. E., Aguilar‐Bryan, L., Bryan, J., Kunze, D. L., Moss, L. G., Nelson, D. A., Rajan, A. S., Raef, H., XIANG, H., & Yaney, G. C. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-571147-0.50013-5 · Cited by 30
The Expanding Role of Oxidative Stress, Renin Angiotensin System, and β-Cell Dysfunction in the Cardiometabolic Syndrome and Type 2 Diabetes Mellitus
Lastra, G., & Manrique, C. M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1615 · Cited by 30
Clinical Measures of Islet Function: Usefulness to Characterize Defects in Diabetes
Åhrén, B., Pratley, R. E., Soubt, M., Dunning, B. E., & Foley, J. E. (2008) · Current Diabetes Reviews · doi:10.2174/157339908784220714 · Cited by 30
Adenovirus‐mediated preproinsulin gene transfer into adipose tissues ameliorates hyperglycemia in obese diabetic KKAy mice
Nagamatsu, S., Nakamichi, Y., Ohara‐Imaizumi, M., Ozawa, S., Katahira, H., Watanabe, T., & Ishida, H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03146-5 · Cited by 31
Early disturbances in insulin secretion in the development of type 2 diabetes mellitus
van Haeften, T. W. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00267-8 · Cited by 30
Clinical Characterization of Insulin Secretion as the Basis for Genetic Analyses
Stümvoll, M., Fritsche, A., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s122 · Cited by 30
Rationale and Methods for the Estimation of Insulin Secretion in a Given Patient
Vague, P., & Nguyen, L. T. K. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s240 · Cited by 30
Increase in B-cells in the pancreatic remnant after partial pancreatectomy in pigs
Löhr, M. J., Liibbersmeyer, J., Otremba, B. J., Klapdor, R., Grossner, D., & Klöppel, G. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890027 · Cited by 30
Impact of Family History of Diabetes and Ethnicity on β-Cell Function in Obese, Glucose-Tolerant Individuals
Rasouli, N., Spencer, H. J., Rashidi, A. A., & Elbein, S. C. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0919 · Cited by 29
Mechanisms for hyperglycemia in type II diabetes mellitus: Therapeutic implications for sulfonylurea treatment—an update
Porte, D., & Kahn, S. E. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90412-q · Cited by 29
Self-citation
Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans
Åhrén, B. (2008) · Diabetologia · doi:10.1007/s00125-008-0995-y · Cited by 31
Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice
Cavelti‐Weder, C., Li, W., Zumsteg, A., Stemann, M., Zhang, Y., Yamada, T., Wang, M. M., Lu, J., Jermendy, Á., Bee, Y. M., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3838-7 · Cited by 28
Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans
Riveline, J., Baz, B., Nguewa, J. L., Vidal-Trécan, T., Ibrahim, F., Boudou, P., Vicaut, É., de la Perrière, A. B., Fetita, L.-S., Bréant, B., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz145 · Cited by 31
‘Resistance is futile?’ – paradoxical inhibitory effects of K ATP channel closure in glucagon‐secreting α‐cells
Zhang, Q., Dou, H., & Rorsman, P. (2020) · The Journal of Physiology · doi:10.1113/jp279775 · Cited by 31
Acute Insulin Response to Intravenous Arginine in Nonobese Healthy Cats
Kitamura, T., Yasuda, J., & Hashimoto, A. (1999) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1999.tb02208.x · Cited by 28
The Appropriate Use of B‐cell Function Testing in the Preclinical Period of Type 1 Diabetes
McCulloch, D. K., & Palmer, J. P. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb02116.x · Cited by 28
Arginine Metabolism Is Altered in Adults with A-β + Ketosis-Prone Diabetes
Mulukutla, S. N., Hsu, J. W.-C., Gaba, R., Bohren, K. M., Guthikonda, A., Iyer, D., Ajami, N. J., Petrosino, J. F., Hampe, C. S., Ram, N., et al. (2018) · Journal of Nutrition · doi:10.1093/jn/nxx032 · Cited by 26
Type 2 Diabetes Mellitus
Buse, J. B., Polonsky, K. S., & Burant, C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00031-6 · Cited by 28
Effect of an oral α2-adrenergic blocker (MK-912) on pancreatic islet function in non-insulin-dependent diabetes mellitus
Ortiz-Alonso, F. J., Herman, W. H., Gertz, B. J., Williams, V. C., Smith, M. J., & Halter, J. B. (1991) · Metabolism · doi:10.1016/0026-0495(91)90210-n · Cited by 27
Self-citation
Failure of beta-cell adaptation in type 2 diabetes: Lessons from animal models
Kaiser, N. (2009) · Frontiers in bioscience · doi:10.2741/3296 · Cited by 26
Vildagliptin action on some adipocytokine levels in type 2 diabetic patients: a 12-month, placebo-controlled study
Derosa, G., Ragonesi, P. D., Carbone, A., Fogari, E., D’Angelo, A., Cicero, A. F. G., & Maffioli, P. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.734499 · Cited by 25
Lixisenatide resensitizes the insulin‐secretory response to intravenous glucose challenge in people with type 2 diabetes – a study in both people with type 2 diabetes and healthy subjects
Becker, R. H. A., Stechl, J., Msihid, J., & Kapitza, C. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12278 · Cited by 24
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus
Urbano, F., Filippello, A., Pino, A. D., Barbagallo, D., Mauro, S. D., Pappalardo, A., Rabuazzo, A. M., Purrello, M., Purrello, F., & Piro, S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00148.2015 · Cited by 25
Altered islet Beta-cell function before the onset of Type 1 (insulin-dependent) diabetes mellitus
Lo, S. S. S., Hawa, M. I., Beer, S. F., Pyke, D. A., & Leslie, R. D. G. (1992) · Diabetologia · doi:10.1007/bf00400930 · Cited by 25
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation
Christiansen, E., Tibell, A., Vølund, A., Rasmussen, K. K., Groth, C. G., Holst, J. J., Pedersen, O. B., Christensen, N. J., & Madsbad, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923846 · Cited by 25
Decreased insulin secretory capacity and normal pancreatic B‐cell glucose sensitivity in non‐obese patients with NIDDM
van Haeften, T. W., MAARSCHALKERWEERD, W. W. A. V., Gerich, J. E., & van der Veen, E. A. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01806.x · Cited by 25
Age-related differences in the pancreatic β-cell response to hyperglycemia after eccentric exercise
Krishnan, R. K., Hernandez, J. M., Williamson, D. L., O’Gorman, D. J., Evans, W. J., & Kirwan, J. P. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.3.e463 · Cited by 25
2 Role of insulin resistance in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus
Gerich, J. E. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80034-x · Cited by 25
The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
Aulinger, B. A., Vahl, T. P., Prigeon, R. L., D'Alessio, D. A., & Elder, D. A. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00496.2015 · Cited by 24
The mass, but not the frequency, of insulin secretory bursts in isolated human islets is entrained by oscillatory glucose exposure
Ritzel, R. A., Veldhuis, J. D., & Butler, P. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00381.2005 · Cited by 23
Pharmacological Actions of Glucagon-Like Peptide-1, Gastric Inhibitory Polypeptide, and Glucagon
Sekar, R., Singh, K., Arokiaraj, A. W. R., & Chow, B. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.05.002 · Cited by 26
Chronicin VivoHyperglycemia Impairs Phosphoinositide Hydrolysis and Insulin Release in Isolated Perifused Rat Islets*
Zawalich, W. S., Zawalich, K. C., Shulman, G. I., & Rossetti, L. (1990) · Endocrinology · doi:10.1210/endo-126-1-253 · Cited by 24
Remission of Diabetes Mellitus in Cats Cannot be Predicted by the Arginine Stimulation Test
Tschuor, F., Zini, E., Schellenberg, S., Wenger, M., Kaufmann, K., Furrer, D., Lutz, T. A., & Reusch, C. E. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2010.0649.x · Cited by 23
Insulin production following intravenous glucose, arginine, and valine: Different pattern in patients with impaired glucose tolerance and non-insulin-dependent diabetes mellitus
Fasching, P., Ratheiser, K., Nowotny, P., Uurzemann, S., Parzer, S. B., & Waldhäusl, W. (1994) · Metabolism · doi:10.1016/0026-0495(94)90109-0 · Cited by 24
BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner
Zhang, F., Dey, D., Bränström, R., Forsberg, L. E., Lu, M. H., Zhang, Q., & Sjöholm, Å. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00444.2008 · Cited by 23
Effects of pioglitazone and metformin on β-cell function in nondiabetic subjects at high risk for type 2 diabetes
Rasouli, N., Kern, P. A., Reece, E. A., & Elbein, S. C. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00221.2006 · Cited by 23
Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis
Lethagen, Å., Ub, E., Hallengren, B., Groop, L., & Tuomi, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8343 · Cited by 27
Protein phosphatases in pancreatic islets
Ortsäter, H., Grankvist, N., Honkanen, R. E., & Sjöholm, Å. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0002 · Cited by 21
Beta-cell function and mass in type 2 diabetes.
Larsen, M. O. (2009) · PubMed · Cited by 22
Strain differences in the attenuation of bone accrual in a young growing mouse model of insulin resistance
Rendina-Ruedy, E., Graef, J. L., Davis, M. R., Hembree, K. D., Gimble, J. M., Clarke, S. L., Lucas, E. A., & Smith, B. J. (2015) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0685-z · Cited by 22
Insulin Secretion and Insulin Sensitivity in Relation to Fasting Glucose in Healthy Subjects
Åhrén, B. (2007) · Diabetes Care · doi:10.2337/dc06-1759 · Cited by 22
Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients
Kurszynska, Y. T., Goulas, S., Wollen, N., & McIntyre, N. (1998) · Journal of Hepatology · doi:10.1016/0168-8278(88)80015-1 · Cited by 22
Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus
Hsia, S. H., Bazargan, M., & Davidson, M. B. (2004) · Metabolism · doi:10.1016/j.metabol.2004.04.007 · Cited by 24
ER Redox Homeostasis Regulates Proinsulin Trafficking and Insulin Granule Formation in the Pancreatic Islet β-Cell
Rohli, K. E., Boyer, C. K., Bearrows, S. C., Moyer, M. R., Elison, W. S., Bauchle, C. J., Blom, S. E., Yu, C.-L., Pope, M. R., 张建朝, et al. (2022) · Function · doi:10.1093/function/zqac051 · Cited by 24
Islet Autoimmunity Identifies a Unique Pattern of Impaired Pancreatic Beta-Cell Function, Markedly Reduced Pancreatic Beta Cell Mass and Insulin Resistance in Clinically Diagnosed Type 2 Diabetes
Subauste, A. R., Gianani, R., Chang, A. M., Plunkett, C. D., Pietropaolo, S. L., Zhang, Y.-J., Barinas‐Mitchell, E., Kuller, L. H., Gałecki, A. T., Halter, J. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106537 · Cited by 21
Self-citation
Advanced Glycation End Products (AGEs) in Diabetic Complications
Bhat, S., Mary, S., Giri, A. P., & Kulkarni, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_19 · Cited by 21
Early Metabolic Markers of Islet Allograft Dysfunction
Baidal, D. A., Faradji, R. N., Messinger, S., Froud, T., Monroy, K., Ricordi, C., & Alejandro, R. (2009) · Transplantation · doi:10.1097/tp.0b013e318195c249 · Cited by 21
Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus
Prigeon, R. L., Jacobson, R. K., Porte, D., & Kahn, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784086 · Cited by 21
Self-citation
Living Donor Pancreas Transplantation
Gruessner, R. W. G., & Sutherland, D. E. R. (2002) · Transplantation Reviews · doi:10.1053/trre.2002.123264 · Cited by 21
Sleeping Islets and the Relationship Between β-Cell Mass and Function
Weir, G. C., & Bonner‐Weir, S. (2011) · Diabetes · doi:10.2337/db10-1808 · Cited by 20
Hyperglucagonemia Does Not Explain the β-Cell Hyperresponsiveness and Insulin Resistance in Dysglycemic Youth Compared With Adults: Lessons From the RISE Study
Kahn, S. E., Mather, K. J., Arslanian, S. A., Barengolts, E., Buchanan, T. A., Caprio, S., Ehrmann, D. A., Hannon, T. S., Marcovina, S. M., Nadeau, K. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0460 · Cited by 21
Outcome of the Glucagon Test Depends upon the Prevailing Blood Glucose Concentration in Type I (Insulin‐dependent) Diabetic Patients
Madsbad, S., Sauerbrey, N., Møller‐Jensen, B., Krarup, T., & Kuhl, C. K. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb09931.x · Cited by 20
The Diabetic Pancreas: A Pathologist’s View
Rahier, J. (1988) · Springer eBooks · doi:10.1007/978-3-642-72691-0_2 · Cited by 20
Insulin action and determinants of glycaemia in a rat model of Type 2 (non-insulin-dependent) diabetes mellitus
Pascoe, W. S., Jenkins, A. B., Kusunoki, M., & Storlien, L. H. (1992) · Diabetologia · doi:10.1007/bf00400919 · Cited by 20
Reproducibility of the Glucagon Test
Arnold‐Larsen, S., Madsbad, S., & Kuhl, C. K. (1987) · Diabetic Medicine · doi:10.1111/j.1464-5491.1987.tb00884.x · Cited by 20

Authors: Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D.
Affiliations: University of Washington (US)
United States Department of Veterans Affairs (US)
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1984-10-01
Volume: 74
Issue: 4
Pages: 1318-1328
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci111542
PMC: PMC425299
OpenAlex: W1969480413
Cited by: 483
References: 37
Citations by year: 2026: 1 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 6 · 2021: 12 · 2020: 13 · 2019: 10 · 2018: 13 · 2017: 8 · 2016: 19 · 2015: 10 · 2014: 19 · 2013: 14 · 2012: 14
FWCI: 10.29
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p30am017047-11, 5r01am012829-17)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: type 2 diabetes, insulin secretion, acute insulin response, arginine stimulation, glucagon response, glucose-stimulated insulin secretion, hyperglycemia, Michaelis-Menten kinetics
MeSH terms: Insulin Secretion, Adult, Aging, Arginine, Blood Glucose, Catecholamines, Diabetes Mellitus, Diabetes Mellitus, Type 2, Glucagon, Humans, Insulin, Islets of Langerhans, Male, Middle Aged, Obesity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks